Product
Vizol S
1 clinical trial
1 indication
Indication
Dry Eye SyndromeClinical trial
Multi-centre, Randomised,Parallel-group, Controlled (Placebo), Double-blind Study to Evaluate the Efficacy, Ocular Tolerability and Safety of Vizol S Lipid Balance in the Adult Patient Population With Moderate to Severe Dry Eye for up to 30 DaysStatus: Completed, Estimated PCD: 2022-12-01